Hormone Replacement Therapy-Related Thrombosis

Why oral estrogen raises clot risk

When estrogen is taken by mouth, it passes through the liver first, where it increases production of clotting factors and reduces natural anticoagulants. This "first-pass" effect tips the balance toward clotting. Estrogen absorbed through the skin bypasses the liver initially, and studies, including large observational studies, have found little or no increase in venous clot risk with standard-dose transdermal estrogen.

How big is the risk?

• In women in their 50s, the baseline risk of a venous blood clot is low, around 1 to 2 per 1,000 women per year.
• Oral HRT roughly doubles that risk, with the greatest increase in the first year of use.
• The risk falls back after stopping.
• Combined estrogen-progestogen pills carry a somewhat higher risk than estrogen alone. Micronized progesterone and dydrogesterone appear to carry lower risk than some synthetic progestogens.
• Tibolone has a smaller effect on VTE but other risks.
• Vaginal estrogen at low doses does not raise clot risk meaningfully.

HRT is also associated with a small increase in stroke risk with oral forms, especially when started after age 60.

Risk factors that add up

• previous deep vein thrombosis or pulmonary embolism
• inherited thrombophilia, such as factor V Leiden or prothrombin mutation
• a first-degree relative with a clot at a young age
• body mass index over 30
• age over 60 when starting
• smoking
• recent surgery, injury or hospitalization
• immobility and long-haul travel
• cancer
• some autoimmune conditions such as antiphospholipid syndrome

Symptoms

Deep vein thrombosis

• swelling of one calf or leg
• pain, cramping or tenderness, often in the calf
• warmth and redness or discoloration
• visible surface veins

Pulmonary embolism

• sudden breathlessness
• sharp chest pain worse on breathing in
• coughing up blood
• fast heartbeat, dizziness or fainting

Diagnosis

• clinical probability scoring (such as Wells score)
• D-dimer blood test to rule out clots in low-risk cases
• compression ultrasound of the leg veins for DVT
• CT pulmonary angiography or a V/Q scan for PE
• testing for thrombophilia is considered in selected women, particularly with a family history

Treatment

• Anticoagulants: usually a direct oral anticoagulant (such as apixaban or rivaroxaban) or low-molecular-weight heparin, for at least 3 months
• Stop oral estrogen at the time of a clot
• Reassess menopause care: after a clot, many experts avoid systemic HRT. If symptoms are severe, transdermal estrogen may sometimes be considered with specialist input, often while anticoagulated
• Non-hormonal options for hot flashes: SSRIs or SNRIs (such as paroxetine or venlafaxine), gabapentin, fezolinetant (a neurokinin-3 receptor antagonist), and cognitive behavioral therapy

Reducing your risk on HRT

• choose transdermal estrogen if you have risk factors for clots, such as a BMI over 30
• use the lowest effective dose
• prefer micronized progesterone if you need a progestogen
• keep active and avoid long periods of immobility
• stop smoking
• discuss stopping oral HRT temporarily before major surgery
• on long flights, walk regularly and stay hydrated

Frequently asked questions

Does HRT cause blood clots?

Oral HRT increases the risk of blood clots in the veins, roughly doubling it, especially in the first year. Transdermal estrogen patches, gels and sprays at standard doses do not appear to significantly increase the risk.

Is the patch safer than the pill for blood clot risk?

Yes. Estrogen delivered through the skin bypasses the liver's first-pass effect and does not appear to raise clot risk at standard doses. Guidelines recommend transdermal estrogen for women with higher clot risk who need HRT.

What are the signs of a blood clot on HRT?

Watch for one swollen, painful, warm or red leg, and for sudden breathlessness, sharp chest pain, coughing blood, fainting or a racing heart. These need urgent medical care.

Can I take HRT if I have had a blood clot?

Systemic HRT is usually avoided after a blood clot. In some cases, with severe symptoms, specialists may consider transdermal estrogen with careful assessment. Non-hormonal treatments and low-dose vaginal estrogen are generally safer options.

Does vaginal estrogen increase clot risk?

Low-dose vaginal estrogen for vaginal dryness and urinary symptoms is absorbed in very small amounts and is not associated with a meaningful increase in blood clot risk.